doi: 10.1038/426216a.
Syngenta ends plant-research deal with Berkeley
- PMID:14628007
- DOI: 10.1038/426216a
Item in Clipboard
Syngenta ends plant-research deal with Berkeley
Rex Dalton. Nature..
Display options
Format
Display options
Format
No abstract available
Similar articles
- Berkeley dispute festers over biotech deal.Dalton R.Dalton R.Nature. 1999 May 6;399(6731):5. doi: 10.1038/19807.Nature. 1999.PMID:10331373No abstract available.
- Faculty start-ups offer temptation to breach academic rules . . . but Syngenta deal is a boon to Berkeley.Metz M.Metz M.Nature. 2001 Mar 29;410(6828):513. doi: 10.1038/35069246.Nature. 2001.PMID:11279462No abstract available.
- Biotech funding deal judged to be 'a mistake' for Berkeley.Dalton R.Dalton R.Nature. 2004 Aug 5;430(7000):598. doi: 10.1038/430598b.Nature. 2004.PMID:15295560No abstract available.
- France's technologies for health program. Promoting collaborative research between academics, clinicians, and industrials in priority areas of medical technology.Beuscart R, Roux C, Cazuguel G, Coatrieux JL, Demongeot J.Beuscart R, et al.IEEE Eng Med Biol Mag. 2008 Jan-Feb;27(1):56-63. doi: 10.1109/memb.2007.911409.IEEE Eng Med Biol Mag. 2008.PMID:18306503Review.No abstract available.
- Medical device research.Boyle J, Maeder A, Bell J, John S, Scott R.Boyle J, et al.Expert Rev Med Devices. 2005 Jan;2(1):41-5. doi: 10.1586/17434440.2.1.41.Expert Rev Med Devices. 2005.PMID:16293027Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources